SEARCH

HOME / SEARCH / Trametinib (plus imatinib in BCR-ABL)

iGMDRD471

Canonical SMILES: CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC(=CC=C4)NC(=O)C)C5CC5

InChI: InChI=1S/C26H23FIN5O4/c1-13-22-21(23(31(3)24(13)35)30-20-10-7-15(28)11-19(20)27)25(36)33(17-8-9-17)26(37)32(22)18-6-4-5-16(12-18)29-14(2)34/h4-7,10-12,17,30H,8-9H2,1-3H3,(H,29,34)

InChI Key: LIRYPHYGHXZJBZ-UHFFFAOYSA-N

Standard Name	CHEMBL	Pubchem CID	DRUGBANK ID	Drug Status	Drug Type
Trametinib (plus imatinib in BCR-ABL)	CHEMBL2105741 CHEMBL2103875	11707100	DB08911	Combination	Small Molecule

Drug Class:

Antineoplastic Agents Antineoplastic and Immunomodulating Agents Cytochrome P-450 Enzyme Inducers Cytochrome P-450 Enzyme Inhibitors Enzyme Inhibitors Heterocyclic Compounds Heterocyclic Compounds, 1-Ring Kinase Inhibitor MAP Kinase Kinase 1, antagonists & inhibitors MAP Kinase Kinase 2, antagonists & inhibitors Protein Kinase Inhibitors Pyridines Pyrimidines

Drug Targets:

MAP2K1 (Q02750)MAP2K2 (P36507)

Drug Pathways:

ERK MAPK signaling

Drug-model tissue-cancer distribution: Bubble Plot

Drug-gene pathway enrichments

Drug-gene GO enrichments

Drug-Gene: Aster Plot

Gene ID	Gene Name	Model Num.
5583	PRKCH	1

Gene in drug-gene network: Network Plot

Models in Trametinib (plus imatinib in BCR-ABL)

SITE

DATATYPES

CLASSFICATION

Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.